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Abstract Cells undergo processes such as proliferation, di¡er-
entiation, and survival based upon cues that they receive from
their microenvironment. Extracellular matrix adhesion mole-
cules, such as integrins and syndecans, and cell^cell adhesion
molecules, including cadherins and Ig superfamily members,
convey information about the environment to the cell. It is evi-
dent that cell adhesion molecules (CAMs) regulate a variety of
signaling events. An emerging theme is that one level of CAM
signaling control is through regulated nucleocytoplasmic distri-
bution of molecules that either phosphorylate or co-activate
transcription factors. In this manner, CAMs control transcrip-
tion events that ultimately have a strong impact on cellular
processes.
" 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
A key step in transcriptional regulation is the transit of
signals generated at the cell surface from the cytoplasm into
the nucleus. Much of our understanding of nuclear import
and export mechanisms has been elucidated through the anal-
ysis of molecules containing consensus nuclear localization
and export signals (NLS and NES). Importin and exportin
adapter molecules recognize consensus NLS and NES, respec-
tively, within target molecules and bind to the nuclear pore
complex. Furthermore, adapter^target binding is regulated by
the Ran GTPase [1]. Recent studies have highlighted a new
function for many cell adhesion molecules (CAMs) in the
regulation of nucleocytoplasmic tra⁄cking. Many modes of
regulation have been described including CAM interaction
with molecules capable of transcriptional co-activation,
CAM regulation of the nuclear accumulation of kinases,
and proteolytic cleavage of CAMs to release fragments that
are able to translocate to the nucleus (Fig. 1). Although many
of the CAM-regulated signaling molecules utilize consensus
NLS or NES, others do not contain such sequences and, in
certain cases, nucleocytoplasmic tra⁄cking may occur inde-
pendently of Ran. Elucidating the mechanisms underlying
CAM-regulated nucleocytoplasmic tra⁄cking will aid our
understanding of the role of adhesive interactions in control-
ling cell fate.
2. Cell adhesion site components with transcriptional
co-activation potential
A direct method whereby CAMs regulate nuclear events is
through the translocation of a signaling protein from an ad-
hesion site to the nucleus upon CAM engagement. The integ-
rin-interacting protein JAB1 (Jun activation domain binding
protein 1) is also a co-activator of the transcription factor
c-Jun. JAB1 associates with L2 integrins in lymphocytes
and, upon KLL2 engagement, translocates into the nucleus
and enhances c-Jun-driven transcription [2]. JAB1 is also
known to facilitate the degradation of the cyclin-dependent
kinase inhibitor, p27 [3], an important cell cycle regulator
that is down-regulated in an adhesion-dependent manner.
Thus, integrin regulation of JAB1 localization has important
implications for cell cycle progression.
Frequently, CAM expression level rather than engagement
regulates the nucleocytoplasmic tra⁄cking of signaling pro-
teins by acting as a cytoplasmic anchor. E-cadherin is a ho-
motypic cell^cell adhesion molecule that binds directly to
L-catenin at adherence junctions. The cytoplasmic accumula-
tion of L-catenin is prevented normally by an axin^APC^
GSK-3L complex that mediates targeting of L-catenin for deg-
radation [4]. However, under circumstances of ine⁄cient
L-catenin degradation, such as upon mutational inactivation
of APC, L-catenin accumulates in the cytoplasm and trans-
locates into the nucleus. Nuclear L-catenin acts as a co-
activator for the transcription factor LEF-1 (lymphocyte en-
hancer binding factor-1) and regulates transcription of growth
control genes such as c-Myc and cyclin D1 [5]. Cytoplasmic
anchoring of CAM-interacting proteins is likely to be an im-
portant determinant in cellular processes. In colon carcinoma
cells containing high levels of nuclear L-catenin, overexpres-
sion of cadherins titrates accumulated L-catenin away from
the nucleus and reduces LEF-1-mediated transcription [6^8].
It should be noted that enhancing expression of L-catenin
cytoplasmic anchors, such as axin, similarly reduces L-catenin
transactivation potential [9]. In mammary epithelial cells,
E-cadherin-mediated sequestration of L-catenin causes cell
cycle arrest, suggesting that E-cadherin acts as a tumor sup-
pressor through control of L-catenin nucleocytoplasmic distri-
bution [10].
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A second example of a CAM acting as a cytoplasmic an-
chor is provided by syndecans. Syndecans are a family of
transmembrane proteoglycans that, via their extracellular
glycosaminoglycan chains, bind many extracellular matrix
(ECM) proteins and growth factors. In addition, the cytoplas-
mic domains of syndecans bind directly to the PDZ domain-
containing proteins CASK and syntenin, and recruit them to
sites away from the nucleus [11,12]. In the nucleus, CASK
interacts with Tbr, a transcription factor involved in forebrain
development [11]. Syntenin interacts with Sox4 and may play
a role in B cell development [13]. These studies indicate that
the cellular levels of CAM are likely to dictate growth and
developmental decisions.
Many additional proteins potentially perform roles both at
cell adhesion sites and in the nucleus (see Table 1). A striking
feature among several of these proteins is that their nuclear
accumulation is often directed by LIM (Lin-11, Isl-1 and Mec-
3) motifs, zinc ¢nger-like structures that mediate protein^pro-
tein interactions [14]. However, the extent to which tra⁄cking
occurs directly from adhesion sites remains unclear. For ex-
ample, paxillin has been reported to enter the nucleus from a
perinuclear rather than focal adhesion pool [15]. Furthermore,
the role that many of these proteins perform in the nucleus
warrants further investigation.
3. Adhesion regulation of ERK nucleocytoplasmic distribution
Integrin-mediated adhesion to the ECM coordinates growth
factor signaling events [35]. Signaling through Ras to the
extracellular signal-regulated kinase (ERK) cascade is critical
for cell cycle progression, a process that requires both ERK
activation and subsequent nuclear translocation of activated
ERK [36]. Adhesion to the ECM has recently been shown to
promote e⁄cient accumulation of activated ERK in the nu-
cleus [37,38], an observation that does not extend to other
mitogen-activated protein kinase subfamilies [39]. Further-
more, ERK nuclear accumulation is impaired in mouse em-
bryo ¢broblasts (MEF-L1del) in which the distal cytoplasmic
portion of the L1 tail is mutated [40]. In addition to ERK
nuclear localization, activation of the GTPase Rac is impaired
in the MEF-L1del cells and notably ERK nuclear accumula-
tion is recovered by expression of a constitutively active Rac.
Fig. 1. Modes of CAM-regulated nucleocytoplasmic tra⁄cking. CAMs regulate the nucleocytoplasmic tra⁄cking of signaling molecules by dif-
ferent means. Engagement of integrins (such as KLL2) can release integrin-interacting proteins (e.g. JAB1), which subsequently translocate to
the nucleus and bind to transcription factors (for example, c-Jun). Additionally, integrin-mediated adhesion enhances nuclear accumulation of
ERK and ERK-mediated phosphorylation of Elk-1, possibly via a Rac-dependent mechanism. Many CAMs can act as cytoplasmic anchors.
Syndecans are able to recruit the PDZ domain-containing proteins, CASK and syntenin; cadherins bind L-catenin (L-CAT). CAM binding de-
pletes the nuclear pool of these molecules with resulting decreases in transcription. Proteolytic cleavage of CAMs may also play a role in tran-
scriptional events. Cleavage of CD44 initially in the extracellular domain and subsequently within the intracellular domain releases a CD44
fragment that translocates to the nucleus and enhances CREB binding protein (CBP)/p300-mediated transactivation potential.
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Studies in myeloid leukemia cell lines have shown a role for
Rho/Rho kinase-associated signaling in cytoplasmic seques-
tration of ERK localization and decreased ERK-mediated
p21Cip1 induction [41]. Such ¢ndings raise the notion of Rac
and Rho acting in an antagonist fashion to regulate ERK
localization [42]. Whether integrins and Rho family GTPases
control ERK localization in an actin-dependent manner,
through regulation of MEK1^ERK2 association [43], or by
an alternative mechanism is not well established. Interestingly,
parallels can be drawn between ERK and L-catenin nucleocy-
toplasmic tra⁄cking. Both localize to the nucleus when highly
expressed, are able to interact directly with nucleoporins in
the nuclear pore complex, and are exported from the nucleus,
at least in part, by the same proteins that act as cytoplasmic
binding partners [44^46]. Given the importance of ERK nu-
clear activity for proliferation, understanding the mechanism
whereby ERK nuclear accumulation is regulated by integrins
is likely to provide important insight into disease states in-
volving anchorage-independent cell growth.
4. Proteolytic release of CAM fragments that contain nuclear
potential
An alternative mode of CAM regulation of nucleocytoplas-
mic tra⁄cking is through proteolytic cleavage of the CAM.
For several years, studies on the Notch receptor have illus-
trated the role of proteolysis in signal transduction. In this
pathway, Notch is cleaved upon binding of its ligand and the
release of an intracellular fragment ensues, which translocates
to the nucleus and regulates transcription events involved in
cell fate determination [47]. Recently, comparable mechanisms
have been proposed whereby CAMs are cleaved to release
either CAM fragments or interacting proteins that contain
transcriptional potential.
CD44 binds matrix hyaluronan, links to the actin cytoskel-
eton, and plays an important role in a variety of cellular pro-
cesses including lymphocyte homing and cell migration [48].
This CAM is sequentially cleaved, initially in the extracellular
domain followed by a second cleavage close to the transmem-
brane-intracellular boundary [49]. Notably, the latter proteo-
lytic event is blocked by an inhibitor of presenilin/Q-secretase,
the same complex involved in Notch processing [42]. The ¢nal
cytoplasmic fragment of CD44 is able to translocate to the
nucleus and potentiate transactivation mediated by the co-
activators CBP and p300. Interestingly, the cleaved CD44
C-terminal fragment enhances transcription of CD44. Thus,
CD44 proteolysis may trigger its own turnover during migra-
tion, a ¢nding of particular interest since CD44 cleavage prod-
ucts have been detected in primary tumor tissue [50].
Studies on E-cadherin also provide evidence for proteolytic
cleavage of CAMs. Under conditions favoring apoptosis,
E-cadherin is sequentially cleaved, ¢rst by a metalloproteinase
and second by a presenilin/Q-secretase-like activity [51,52]. Re-
lease of the cytoplasmic E-cadherin fragment disrupts cadher-
in^L-catenin complexes leading to an increase in the cytosolic
fraction of L-catenin. As discussed above, elevated cytosolic
L-catenin levels are associated with increased L-catenin nu-
clear accumulation and LEF-1-mediated transcription, hence
the implication is that presenilin-mediated proteolytic cleav-
age of E-cadherin may contribute to enhanced transcription
of genes involved in survival. However, other ¢ndings show
that presenilin de¢ciency leads to elevated L-catenin and cy-T
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clin D1 levels in primary ¢broblasts and accelerated tumor
formation in vivo [53,54]. Nevertheless, these studies highlight
the emerging theme of proteolysis of CAMs and its possible
involvement in regulating the localization and nuclear signal-
ing of CAM fragments and CAM-associated proteins.
5. Summary
The localization of signaling molecules determines their
ability to act as co-activators or to phosphorylate transcrip-
tion factors. Thus, the ability of CAMs to alter the nucleocy-
toplasmic tra⁄cking of signaling molecules is an important
aspect of cellular decision-making processes. Altered localiza-
tion of the signaling molecules is frequently associated with
disease states, especially forms of cancer. Hence, understand-
ing how CAMs regulate the nucleocytoplasmic tra⁄cking of
these signaling molecules will likely be key for understanding
disease processes and provide the rationale for design of novel
therapies.
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